How do tumor cells respond to HDAC inhibition?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How do tumor cells respond to HDAC inhibition?

Published:2016-05-10 Issue:22 Volume:283 Page:4032-4046
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Newbold Andrea¹²,Falkenberg Katrina J.³,Prince H. Miles²⁴,Johnstone Ricky W.¹²

Affiliation:

1. Cancer Therapeutics Program; The Peter MacCallum Cancer Centre; East Melbourne Vic. Australia

2. Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville Vic. Australia

3. IMP - Research Institute of Molecular Pathology; Vienna Austria

4. Division of Cancer Medicine; The Peter MacCallum Cancer Centre; East Melbourne Vic. Australia

Funder

National Health and Medical Research Council

Cancer Council Victoria

Victorian Cancer Agency

Leukaemia Foundation

Snowdome Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/febs.13746/fullpdf

Reference150 articles.

1. Genetic syndromes caused by mutations in epigenetic genes;Berdasco;Hum Genet,2013

2. Genetic and epigenetic regulators of pluripotency;Surani;Cell,2007

3. Cancer epigenetics: from mechanism to therapy;Dawson;Cell,2012

4. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders;Falkenberg;Nat Rev Drug Discovery,2014

5. Epigenetics and oncology;Mummaneni;Pharmacotherapy,2014

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics and immunotherapy in colorectal cancer: progress and promise;Clinical Epigenetics;2024-09-10

2. Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma;2024-07-02

3. Chloroquine-induced DNA damage synergizes with DNA repair inhibitors causing cancer cell death;Frontiers in Oncology;2024-05-13

4. Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids;Biomedicine & Pharmacotherapy;2024-04

5. Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2023-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3